|
RSL24D1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.38869999999292E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.197100E-04 |
| Normal-vs-Stage2 |
6.197000E-04 |
| Normal-vs-Stage3 |
5.5884000000006E-05 |
| Normal-vs-Stage4 |
2.381000E-04 |
| Stage1-vs-Stage2 |
3.385800E-01 |
| Stage1-vs-Stage3 |
3.342800E-01 |
| Stage1-vs-Stage4 |
5.096600E-01 |
| Stage2-vs-Stage3 |
8.027400E-01 |
| Stage2-vs-Stage4 |
7.781800E-01 |
| Stage3-vs-Stage4 |
9.403800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.15519999999803E-05 |
| Normal-vs-AfricanAmerican |
6.749700E-02 |
| Normal-vs-Asian |
7.003500E-04 |
| Caucasian-vs-AfricanAmerican |
2.631800E-01 |
| Caucasian-vs-Asian |
8.413800E-01 |
| AfricanAmerican-vs-Asian |
3.406400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.09719999999525E-05 |
| Normal-vs-Female |
2.561700E-04 |
| Male-vs-Female |
3.706200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.503800E-03 |
| Normal-vs-Age(41-60Yrs) |
8.46979999999942E-05 |
| Normal-vs-Age(61-80Yrs) |
1.88338999999038E-05 |
| Normal-vs-Age(81-100Yrs) |
1.430320E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.271800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.359230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.547600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.764400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.374000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.271600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.426000E-01 |
| Classical-VS-Follicular |
1.819030E-01 |
| Classical-VS-Other |
4.572200E-01 |
| Classical-VS-Normal |
4.640500E-04 |
| Tall-VS-Follicular |
9.435000E-01 |
| Tall-VS-Other |
3.062800E-01 |
| Tall-VS-Normal |
2.103500E-03 |
| Follicular-VS-Other |
3.279800E-01 |
| Follicular-VS-Normal |
2.186500E-04 |
| Other-VS-Normal |
5.175400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.62580000000667E-05 |
| Normal-vs-N1 |
2.47899999999968E-05 |
| N0-vs-N1 |
3.979200E-01 |
|
|
